DALLAS AND SAN DIEGO, Feb. 24, 2026 /PRNewswire/ — Huitt-Zollars, Inc., an employee-owned, full-service design firm headquartered in Dallas, Texas, today announcedDALLAS AND SAN DIEGO, Feb. 24, 2026 /PRNewswire/ — Huitt-Zollars, Inc., an employee-owned, full-service design firm headquartered in Dallas, Texas, today announced

Design Firm Huitt-Zollars Strengthens Federal Design Expertise and Architectural Capabilities in San Diego with Acquisition of Vasquez Marshall Architects (VMA)

2026/02/25 00:31
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

DALLAS AND SAN DIEGO, Feb. 24, 2026 /PRNewswire/ — Huitt-Zollars, Inc., an employee-owned, full-service design firm headquartered in Dallas, Texas, today announced the acquisition of Vasquez Marshall Architects (VMA), a San Diego-based firm recognized for its Federal design expertise and complementary experience in higher education, commercial, and interior architecture.

With this acquisition, Huitt-Zollars’ current San Diego office will merge with the VMA team, creating a larger, integrated practice that enhances the firm’s ability to support Federal agencies and mission-driven clients across the region. The combined team brings a deep understanding of complex design-build delivery and high-performance architectural solutions, supported by Huitt-Zollars’ national resources and technical expertise.

“VMA’s Federal design–build expertise is a strong addition to our San Diego team,” said Robert McDermott, President of Huitt-Zollars. “Together, we’ll expand our capabilities and better serve our clients across the region.”

VMA has established itself as a trusted partner on Federal design-build teams as well as to Federal agencies on mission-focused projects. Their broader project experience includes academic buildings, campus improvements, workplace environments, and thoughtfully crafted interiors, reflecting a versatile skill set that complements Huitt-Zollars’ multidisciplinary approach.

“Partnering with Huitt-Zollars allows us to elevate what we can offer our clients, especially on large, integrated Federal projects,” said David Vasquez and Robert Bodenhamer, Principals at VMA. “It allows us to offer our clients expanded services, greater resources, and the ability to support projects at a larger scale while maintaining the service they expect from us.”

The combined San Diego team strengthens Huitt-Zollars’ presence in Southern California, expanding the firm’s multidisciplinary capabilities across public-sector and private-sector markets.

About Vasquez Marshall Architects

Vasquez Marshall Architects (VMA) is a San Diego–based architectural design firm recognized as one of the leading practices in the region for its professionalism, quality, and timeless design approach. The firm’s leadership has worked together for more than 31 years, cultivating a strong reputation for hands–on project involvement and a long history of repeat clients. Their expertise spans design of complex Federal projects, as well as for public and private clients.

About Huitt-Zollars, Inc.

Huitt–Zollars is a national, 100% employee–owned, full–service design firm committed to delivering innovative, client–focused solutions for the built environment. Founded in 1975 and headquartered in Dallas, the firm has grown into a coast–to–coast presence, providing multidisciplinary expertise across commercial, institutional, industrial, federal, public works, transportation, and urban development markets. Guided by its purpose, to constantly improve the quality of life in our world, the firm approaches every assignment with a commitment to listening, partnering, and delivering solutions that meet community needs today and into the future.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/design-firm-huitt-zollars-strengthens-federal-design-expertise-and-architectural-capabilities-in-san-diego-with-acquisition-of-vasquez-marshall-architects-vma-302695163.html

SOURCE Huitt-Zollars, Inc.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09